Fig. 1.
Observed pre-dose concentrations of 10–1074 and VRC01LS at 28 days following single and dual bNAb administration. Lines connect the values from participants evaluated in both Phase A and B.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.